Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Depreciation & Amortization (CF) (2022 - 2025)

Historic Depreciation & Amortization (CF) for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to $19000.0.

  • Praxis Precision Medicines' Depreciation & Amortization (CF) fell 7934.78% to $19000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $201000.0, marking a year-over-year decrease of 5236.97%. This contributed to the annual value of $400000.0 for FY2024, which is 740.74% down from last year.
  • As of Q3 2025, Praxis Precision Medicines' Depreciation & Amortization (CF) stood at $19000.0, which was down 7934.78% from $46000.0 recorded in Q2 2025.
  • Praxis Precision Medicines' Depreciation & Amortization (CF)'s 5-year high stood at $119000.0 during Q2 2022, with a 5-year trough of $19000.0 in Q3 2025.
  • Moreover, its 4-year median value for Depreciation & Amortization (CF) was $105000.0 (2022), whereas its average is $90866.7.
  • Per our database at Business Quant, Praxis Precision Medicines' Depreciation & Amortization (CF) soared by 1397.85% in 2023 and then plummeted by 7934.78% in 2025.
  • Praxis Precision Medicines' Depreciation & Amortization (CF) (Quarter) stood at $105000.0 in 2022, then grew by 5.71% to $111000.0 in 2023, then decreased by 19.82% to $89000.0 in 2024, then crashed by 78.65% to $19000.0 in 2025.
  • Its last three reported values are $19000.0 in Q3 2025, $46000.0 for Q2 2025, and $47000.0 during Q1 2025.